• Home
  • Store
    • Total Access Subscriptions
    • Newsletter Subscriptions
    • Multimedia
    • Books
    • eBooks
    • ABPN SA Courses
    • Institutional Site Licenses
  • CME Center
  • Multimedia
    • Podcast
    • Webinars
    • Blog
  • Newsletters
    • General Psychiatry
    • Child Psychiatry
    • Addiction Treatment
    • Hospital Psychiatry
    • Geriatric Psychiatry
    • Psychotherapy and Social Work
  • Toolkit/AskCarlat AI
  • FAQs
  • Log In
  • Register
  • Welcome
  • Sign Out
  • Subscribe
Access Purchased Content
Home » Authors » Carlat Staff

Articles by Carlat Staff

Research Update

CBT for Depression Works Just as Well in Older Adults

October 1, 2026
Carlat Staff
From The Carlat Geriatric Psychiatry Report
Issue Links: Editorial Information | PDF of Issue

Compiled by Carlat Editorial Staff and Reviewed by the Editor-in-Chief and the Editorial Board.

Staff members have no financial relationships with companies related to this material.

 Older adults receive less psychotherapy than any other age group, partly on the assumption that talk therapy works less well in late life. Does the evidence back that assumption up?


Read More
Research Update

Escitalopram Doesn't Replace Citalopram for Agitation in Alzheimer's Disease

October 1, 2026
Carlat Staff
From The Carlat Geriatric Psychiatry Report
Issue Links: Editorial Information | PDF of Issue

Compiled by Carlat Editorial Staff and Reviewed by the Editor-in-Chief and the Editorial Board.

Staff members have no financial relationships with companies related to this material.

Citalopram works for agitation in Alzheimer's disease but comes with QTc concerns and strict dosing limits. Escitalopram, its purer enantiomer, seemed like an obvious fix. Is it as effective for agitation?


Read More
Research Update

Choosing a Diabetes Drug? GLP-1 Agonists May Also Protect the Brain

October 1, 2026
Carlat Staff
From The Carlat Geriatric Psychiatry Report
Issue Links: Editorial Information | PDF of Issue

Compiled by Carlat Editorial Staff and Reviewed by the Editor-in-Chief and the Editorial Board.

Staff members have no financial relationships with companies related to this material.

Diabetes raises dementia risk, and guidelines already favor GLP-1 agonists and SGLT2 inhibitors for cardiovascular protection. Does either class also guard against cognitive decline? A pooled analysis of 23 trials offers a surprising split.


Read More
Research Update

Pimavanserin Moves Toward First-Line Use for Parkinson's Psychosis

October 1, 2026
Carlat Staff
From The Carlat Geriatric Psychiatry Report
Issue Links: Editorial Information | PDF of Issue

Compiled by Carlat Editorial Staff and Reviewed by the Editor-in-Chief and the Editorial Board.

Staff members have no financial relationships with companies related to this material.

Antipsychotics can worsen motor symptoms and raise mortality in Parkinson's disease psychosis, leaving clinicians with few good options. Could an industry-funded expert panel's new algorithm change practice for these patients?


Read More
Research Update

Antidepressant Black-Box Warnings May Have Increased Harm in Youth

October 1, 2026
Carlat Staff
From The Carlat Child Psychiatry Report
Issue Links: Editorial Information | PDF of Issue

The FDA’s 2004 black-box warning aimed to boost suicidality monitoring in youth on antidepressants. Two decades and thousands of prescriptions later, did it work—or did it quietly reshape treatment patterns in unintended ways?


Read More
Research Update

Slow Down and Individualize Antidepressant Deprescribing in Youth

October 1, 2026
Carlat Staff
From The Carlat Child Psychiatry Report
Issue Links: Editorial Information | PDF of Issue

Compiled by Carlat Editorial Staff and Reviewed by the Editor-in-Chief and the Editorial Board.

Staff members have no financial relationships with companies related to this material.

Adult tapering rules don’t always translate cleanly to children and teens. A new systematic review asks which antidepressants carry the highest withdrawal risk in youth, and just how slow a taper needs to be.


Read More
Research Update

Methylphenidate vs Atomoxetine: Who Wins on ‘Other’ ADHD Symptoms?

October 1, 2026
Carlat Staff
From The Carlat Child Psychiatry Report
Issue Links: Editorial Information | PDF of Issue

Compiled by Carlat Editorial Staff and Reviewed by the Editor-in-Chief and the Editorial Board.

Staff members have no financial relationships with companies related to this material.

Stimulant versus non-stimulant for ADHD is a familiar debate. A head-to-head trial looks beyond core symptoms to executive function and emotional side effects—where do the two agents diverge?


Read More
Research Update

Atypical Antipsychotics May Promote Growth in Pediatric ARFID

October 1, 2026
Carlat Staff
From The Carlat Child Psychiatry Report
Issue Links: Editorial Information | PDF of Issue

Compiled by Carlat Editorial Staff and Reviewed by the Editor-in-Chief and the Editorial Board.

Staff members have no financial relationships with companies related to this material.

Avoidant/restrictive food intake disorder can stall despite months of good therapy, leaving weight and growth stuck. Could a low-dose atypical antipsychotic help these underweight, treatment-resistant youth finally turn the corner?


Read More
Research Update

When Antidepressants Stop Working in Older Adults

July 1, 2026
Carlat Staff
From The Carlat Geriatric Psychiatry Report
Issue Links: Editorial Information | PDF of Issue

Carlat Staff

The evidence base for treatment-resistant depression was largely built on younger adults. This meta-analysis asks what works in patients 55 and older. One intervention stands out, especially when suicidality is in the picture.


Read More
Research Update

Physical Activity and Mental Health: How Much Is Enough?

July 1, 2026
Carlat Staff
From The Carlat Geriatric Psychiatry Report
Issue Links: Editorial Information | PDF of Issue

Carlat Staff

How much exercise does it take to protect against depression and anxiety in older adults? A large accelerometer-based study puts a number on it, and finds the biggest gains happen at the very bottom of the activity spectrum.


Read More
Previous 1 2 Next
Try The New AskCarlat AI

Ask any clinical question—our AI responds using only the peer-reviewed, editorially vetted content from Carlat Publishing.

Available In The Carlat Toolkit
Free Psychiatry Updates
The latest unbiased psychiatric information sent to your inbox.
Specify Your Interests
Featured Book
  • CAM1e_3DCover_Spiral_sm.png

    Complementary and Alternative Medicine in Psychiatry: A Fact Book (2026) -

    Fact sheets for 67 treatments that fall outside conventional psychopharmacology.
    READ MORE
Featured Video
  • KarXT (Cobenfy)_ The Breakthrough Antipsychotic That Could Change Everything.jpg
    General Psychiatry

    KarXT (Cobenfy): The Breakthrough Antipsychotic That Could Change Everything

    Read More
Featured Podcast
  • shutterstock_2205347851.jpg
    General Psychiatry

    Balancing Focus and Cardiovascular Risk with ADHD Treatment

    Listen now
Recommended
  • Join Our Writing Team

    July 18, 2024
    WriteForUs.png
  • Insights About a Rare Transmissible Form of Alzheimer's Disease

    February 9, 2024
    shutterstock_2417738561_PeopleImages.com_Yuri A.png
  • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

    May 24, 2024
    DEA_Checkbox.png
  • Join Our Writing Team

    July 18, 2024
    WriteForUs.png
  • Insights About a Rare Transmissible Form of Alzheimer's Disease

    February 9, 2024
    shutterstock_2417738561_PeopleImages.com_Yuri A.png
  • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

    May 24, 2024
    DEA_Checkbox.png
  • Join Our Writing Team

    July 18, 2024
    WriteForUs.png
  • Insights About a Rare Transmissible Form of Alzheimer's Disease

    February 9, 2024
    shutterstock_2417738561_PeopleImages.com_Yuri A.png
  • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

    May 24, 2024
    DEA_Checkbox.png

About

  • About Us
  • CME Center
  • FAQ
  • Contact Us

Shop Online

  • Newsletters
  • Multimedia Subscriptions
  • Books
  • eBooks
  • ABPN Self-Assessment Courses

Newsletters

  • The Carlat Psychiatry Report
  • The Carlat Child Psychiatry Report
  • The Carlat Addiction Treatment Report
  • The Carlat Hospital Psychiatry Report
  • The Carlat Geriatric Psychiatry Report
  • The Carlat Psychotherapy Report

Contact

carlat@thecarlatreport.com

866-348-9279

PO Box 626, Newburyport MA 01950

Follow Us

Please see our Terms and Conditions, Privacy Policy, Subscription Agreement, Use of Cookies, and Hardware/Software Requirements to view our website.

© 2026 Carlat Publishing, LLC and Affiliates, All Rights Reserved.